Skip to content
The GMP Insider podcast artwork

The GMP Insider

by Tushar Arora

GMP Insider is your go-to podcast for practical insights into pharmaceutical quality, Good Manufacturing Practices (GMP), and regulatory compliance.Designed for quality professionals, manufacturing teams, and pharma leaders, this show breaks down complex regulations into clear, real-world guidance. Each episode explores topics like audits, CAPA, data integrity, quality systems, validation, and global regulatory expectations — all with a focus on protecting patients and building strong quality cultures.Whether you work in Quality Assurance, Quality Control, Manufacturing, or Regulatory Affairs, GMP Insider helps you stay compliant, confident, and ahead in an ever-evolving pharmaceutical industry.New episodes deliver:• GMP best practices• Audit readiness strategies• Real compliance case studies• Industry trends and updates• Expert tips from quality professionals From batch to patient — quality is everything.

From the show's RSS feed, refreshed Nov 11, 2026. Source feed.

Subscribe Bookmark

Episodes

  1. Environmental Monitoring: Alert vs Action Limits & Trending

    An environmental monitoring programme can collect data for a year and still know nothing — thousands of results, beautifully filed, never trended, never questioned. Marcus and Priya lay out EM done properly: alert limits built from your own baseline, trending by location, organism and operator,...

  2. ICH Q9(R1) Quality Risk Management: What's Actually New

    Most quality risk assessments fail in the first ten minutes, when someone picks a score out of the air and the room nods. Marcus and Priya break down what the ICH Q9(R1) revision actually changed: formality that follows risk, subjectivity named and managed as a bias problem, product availability…

    more
  3. Change Control Management: What Gets Companies in Trouble

    The most dangerous change in a GMP plant is not the big capital project everyone debates for a year — it is the small one nobody logged, because someone called it like for like. Marcus and Priya walk through change control management: what the system is actually for, the invisible changes that...

  4. Contamination Control Strategy (CCS) Under EU GMP Annex 1

    Most contamination control strategies fail on page one — not because anything in them is wrong, but because everything in them is copied from somewhere else. Marcus and Priya break down the CCS under EU GMP Annex 1: what it actually has to contain, how facility design, people, sterilisation…

    more
  5. Deviation Investigation & Root Cause Analysis: 5 Whys Done Right

    Most deviation investigations fail not because teams pick the wrong tool, but because they stop asking why the moment the answer becomes uncomfortable — usually at "human error" and a retraining record. Marcus and Priya walk through a real investigation: containment and timeline reconstruction in...

  6. How to Respond to an FDA 483 (and Warning Letter) in 15 Working Days

    The inspection is over — and the second half of it has just started. Your written response to a Form FDA 483 is due within 15 working days, and FDA weighs it before deciding whether the matter ends there or escalates to a Warning Letter. Marcus and Priya lay out the full 15-day playbook: what a…

    more
  7. FDA Inspection Readiness 2026: The New Cross-System Inspection Model

    FDA doesn't inspect your quality systems in silos anymore. The new inspection model is hypothesis-driven: the investigator pulls one thread — a complaint, a repeat deviation — through CAPA, risk management, and design as a single connected system, and watches whether your story holds. Marcus and...

  8. Why FDA Rejects Your CAPA: 5 CAPA Effectiveness Failures Explained

    Nearly nine out of ten human-drug warning letters include at least one inadequate CAPA response. Your corrective action plan is the single most rejected document in FDA enforcement — and it's not for lack of effort. Marcus and Priya count down the five CAPA effectiveness failures that keep…

    more
  9. Why FDA Rejects Your CAPA: 5 CAPA Effectiveness Failures Explained

    Nearly nine out of ten human-drug warning letters include at least one inadequate CAPA response. Your corrective action plan is the single most rejected document in FDA enforcement — and it's not for lack of effort. Marcus and Priya count down the five CAPA effectiveness failures that keep…

    more
  10. OOS Investigation Explained: Phase 1 vs Phase 2 (21 CFR 211.192)

    An out-of-specification result lands on your desk — and one wrong decision in the next hour can manufacture the evidence for your own warning letter. Marcus and Priya break down the two-phase OOS investigation step by step: Phase 1, the laboratory investigation, and Phase 2, the full-scale...

  11. ALCOA+ Explained: The 9 Data Integrity Principles FDA Actually Cites

    When an FDA investigator stops trusting your data, the inspection is over — because if the records can't be trusted, nothing built on them can be. Marcus and Priya break down all nine ALCOA+ principles — Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring,...

  12. Top 10 FDA 483 Observations in 2026 (and How to Avoid Each One)

    Every year, FDA investigators write thousands of 483 observations — and almost every one was avoidable. Marcus and Priya count down the ten most-cited observations in drug manufacturing for 2026, what investigators are actually finding, and exactly how to keep your site off the list. • The #1...

  13. Quality Debt: The Hidden Liability Inside Pharmaceutical Quality Systems

    Every shortcut, deferred CAPA, and "we'll fix it later" is a loan — and quality debt charges interest. Repeat deviations, findings, and warning letters are just the payments coming due. • What quality debt is and how it silently accumulates • The interest payments: repeat deviations and FDA...

  14. The Hidden Cost of Poor Quality: The Business Impact Beyond Recalls

    Recalls make the headlines. But the real cost of poor quality never makes the press release — it hides in rework, investigations, remediation, and the launches that never happen. • The costs nobody puts on the recall announcement • Rework, investigations, and remediation: the real math • How poor...

  15. Why CAPA Doesn't Fix Culture: Symptoms vs Systems

    Your CAPA system can be perfect on paper and still change nothing — because CAPAs fix symptoms, and culture is the system underneath. • Why brilliant CAPAs die in broken cultures • Symptoms vs systems: knowing which one you're treating • What culture change actually requires from QA leaders •...

  16. Compliance vs Effectiveness: Is Your Quality System Healthy?

    Compliant doesn't mean effective. Effective doesn't mean sustainable. Most quality systems are only one of the three — and leadership can't tell which. • The three lenses every quality system needs • Why compliance alone is a fragile victory • Measuring effectiveness, not just activity • Building…

    more
  17. When a Green Dashboard Lies: Signals Your Metrics Miss

    Every metric green, every trend flat — and the system is rotting underneath. Dashboards don't lie on purpose. They lie by design. • Why green metrics create dangerous comfort • The quality signals dashboards systematically miss • What to measure when the numbers look fine • Leading beyond the...

  18. When Quality Has to Say NO: Tough QA Decisions in Pharma

    Saying no in QA is easy on paper and brutal in practice. This episode is about the decision nobody wants to make — and why making it is the job. • Why "no" is a quality decision, not a career risk • How great QA leaders frame rejection so it actually lands • The difference between blocking…

    more
  19. AI Governance in Pharma: Ethics by Design for Quality Leaders

    AI governance in the pharmaceutical industry cannot begin after deployment. By that point, critical decisions about data, accountability, human oversight, transparency, risk, and system behavior have already been embedded into the technology. So the better question is: What if ethics were…

    more
  20. Big Pharma vs Small Pharma: Where Quality Culture Thrives

    What is it really like to work in Quality Assurance at a large pharmaceutical company compared with a smaller organization? The answer goes far beyond company size. In this episode of The GMP Insider, we explore how Big Pharma and Small Pharma can develop very different professional skills,...

  21. The Human Side of Pharma Quality: Quality Is Love in Action

    What if the deepest meaning of Pharmaceutical Quality isn't compliance? What if it's caring? Every SOP written, every deviation investigated, every batch reviewed, and every quality decision made represents something bigger than a regulatory requirement. It represents a person who cared enough to...

  22. QA Leadership: Making Difficult Quality Decisions with Confidence

    Some of the hardest decisions in Pharmaceutical Quality are not difficult because the answer is unclear. They're difficult because the right answer isn't necessarily the popular one. A Quality Leader may have to say no. They may have to escalate an uncomfortable issue. They may have to challenge...

  23. The Most Dangerous Day in Quality: When Questions Stop

    The most dangerous day in Pharmaceutical Quality isn't necessarily the day an inspector arrives. It may be the day people stop asking questions. A Quality System can appear completely compliant while a much deeper problem develops beneath the surface. SOPs are followed. CAPAs are closed. Metrics...

  24. Beyond CAPA Closure: The QA Judgment That Gets You Promoted

    In Quality Assurance, we often measure success through activity. How many CAPAs were closed? How many deviations were completed? How many investigations were approved? Those metrics are important. But they don't tell the complete story of leadership. In this episode of The GMP Insider, we explore…

    more
  25. The One Lesson Nobody Teaches You in QA

    Technical knowledge is essential in Pharmaceutical Quality Assurance—but it isn't what separates good professionals from exceptional ones. Curiosity does. In this episode of The GMP Insider, we explore why curiosity is one of the most valuable skills a QA professional can develop and how asking...

  26. Quality by Character: Confidence Through Leadership

    The most effective Quality Leaders are not remembered for the number of audits they passed or the investigations they closed. They are remembered for the culture they created. In this episode of The GMP Insider, we explore the principle of Quality by Character and why leadership rooted in...

  27. Quality by Service: Patients, Not Auditors

    In the pharmaceutical industry, inspections, audits, and regulatory compliance are essential. But they are not the ultimate purpose of quality. The true purpose of every Quality Management System is to protect patients by ensuring that every medicine is safe, effective, reliable, and consistently...

  28. Quality by Purpose: Why You Chose Pharma QA

    Pharmaceutical Quality Assurance is often associated with procedures, investigations, documentation, and regulatory compliance. While these responsibilities are essential, they are not the reason most professionals entered the industry. In this episode of The GMP Insider, we explore the principle...

  29. Quality by Trust: Why Patients Trust Pharma QA

    Pharmaceutical quality is built behind the scenes. Patients rarely see the people, processes, investigations, or systems that ensure the medicines they receive are safe, effective, and reliable. Yet every prescription filled and every dose taken reflects an extraordinary act of trust. In this...

  30. Quality by Humility: What Every Deviation Teaches QA

    Every pharmaceutical quality system experiences deviations. The difference between average organizations and exceptional ones is not the number of deviations they encounter—it is how they respond to them. In this episode of The GMP Insider, we explore the principle of Quality by Humility and why...

  31. Quality by Ownership: Quality Is Everyone's Responsibility

    One of the most common misconceptions in the pharmaceutical industry is that Quality Assurance alone owns quality. In reality, QA governs the Quality Management System—but quality is created by every individual who designs, manufactures, tests, reviews, and releases a product. In this episode of...

  32. Quality by Integrity: Doing Right When Nobody Is Watching

    In Pharmaceutical Quality Assurance, compliance establishes expectations—but integrity determines how those expectations are fulfilled. Integrity is demonstrated not during inspections, but in the countless everyday decisions made when no one is watching. In this episode of The GMP Insider, we...

  33. Quality by Curiosity: Better Questions in Pharma QA

    Curiosity is often associated with learning, but in Pharmaceutical Quality Assurance it is also one of the most powerful tools for preventing recurring issues and strengthening quality systems. In this episode of The GMP Insider, we explore why curiosity is a defining characteristic of…

    more
  34. Quality by Courage: Speaking Up Protects Patients

    In Pharmaceutical Quality Assurance, technical knowledge is essential—but it is not enough. Protecting patients also requires the courage to raise concerns, challenge assumptions, and speak up when quality is at risk. In this episode of The GMP Insider, we explore why courage is one of the most...

  35. WE CARE: The Heart of Pharmaceutical Quality

    Quality in the pharmaceutical industry extends beyond procedures, compliance, and inspections. At its core, quality is a commitment to the patients who rely on safe and effective medicines. In this episode of The GMP Insider, we explore the philosophy behind "WE CARE" and why caring is one of the...

  36. Quality by Emotion: The Missing Piece in Pharma QA

    The pharmaceutical industry has long embraced concepts such as Quality by Design, Quality Culture, Risk Management, and Continuous Improvement. These principles remain essential to building robust quality systems. But is there another dimension that deserves equal attention? In this episode of…

    more
  37. Data Integrity in Pharma: It Starts Before Data Is Created

    Data integrity is often discussed as a documentation concern, but its true foundation begins much earlier — with process design. In this episode of The GMP Insider, we examine why reliable data depends on clear workflows, defined responsibilities, adequate controls, and systems that make the…

    more
  38. FDA Inspection Readiness: A Daily Habit, Not a Project

    Inspection readiness is often misunderstood as a project that begins shortly before a regulatory inspection. In reality, the strongest pharmaceutical organizations demonstrate inspection readiness every day through disciplined quality systems and operational excellence. In this episode of The GMP...

  39. AI Governance in Pharma: The Next Big Challenge for QA

    Artificial Intelligence is rapidly becoming part of pharmaceutical operations, supporting drug development, manufacturing, pharmacovigilance, quality management, and regulatory decision-making. While AI offers significant opportunities to improve efficiency and decision-making, its successful...

  40. Weak CAPAs: The Hidden Cost of Closing Without Fixing

    Corrective and Preventive Actions (CAPAs) are among the most important components of a Pharmaceutical Quality Management System. Yet many organizations measure success by closure dates rather than long-term effectiveness. In this episode of The GMP Insider, we examine the hidden costs of...

  41. Quality by Design vs Inspection: What Works in Pharma QA

    Can quality truly be inspected into a pharmaceutical product, or must it be built into the process from the very beginning? In this episode of The GMP Insider, we examine the difference between Quality by Design (QbD) and Quality by Inspection, and why prevention is the foundation of sustainable...

  42. WE DO: The Quality Mindset That Protects Patients

    In pharmaceutical quality, success is not built on intentions alone. It is built on consistent actions. Quality. Compliance. Teamwork. Improvement. These are not just words on a poster. They are commitments that shape every decision, every process, and every product that reaches a patient. In…

    more
  43. Every NO Gets You Closer to YES: A QA Mindset for Pharma

    In pharmaceutical Quality, not every setback is a failure. A deviation, audit observation, rejected batch, or unexpected result can feel like a "NO" in the moment. But the strongest quality organizations understand that these events are often valuable feedback, revealing opportunities to…

    more
  44. AI in Pharma QA: Why Trust Matters More Than Technology

    As Artificial Intelligence becomes increasingly integrated into pharmaceutical operations, organizations face a new challenge: ensuring AI systems are not only powerful, but trustworthy. In this episode of The GMP Insider, we examine the foundational principles of AI Governance and why strong...

  45. QA Career Growth: Stop Sabotaging Your Potential in Pharma

    Career growth in Pharmaceutical Quality Assurance requires more than completing tasks and following procedures. The most successful QA professionals develop a deeper understanding of risk, systems, compliance, and continuous improvement. In this episode of The GMP Insider, we discuss the mindset...

  46. Focused Work in Pharma QA: Your Competitive Advantage

    In pharmaceutical Quality Assurance, many quality failures are not caused by lack of effort, but by fragmented attention, rushed decisions, and surface-level analysis. In this episode of The GMP Insider, we examine why focused work is becoming a critical advantage in regulated industries and how...

  47. Fixed vs Growth Mindset in Pharma Quality

    Mindset plays a critical role in the effectiveness of pharmaceutical quality systems. While some organizations focus only on maintaining compliance, others continuously evaluate risk, strengthen controls, and improve processes over time. In this episode of The GMP Insider, we explore the…

    more
  48. Why Quality Failures Never Happen Overnight in Pharma

    Quality failures in the pharmaceutical industry rarely occur suddenly. They are often the result of unaddressed trends, missed signals, and system weaknesses that develop gradually over time. In this episode of The GMP Insider, we examine how quality issues evolve and why organizations must focus...

  49. Deep Work in Pharma QA: Focus That Improves Quality Systems

    In pharmaceutical Quality Assurance, much of the daily workload can appear productive — emails, meetings, updates, and routine reviews. However, the work that truly strengthens quality systems requires focused, uninterrupted thinking. In this episode of The GMP Insider, we explore the concept of...

  50. Quality Is Not a Department: The Bigger Picture in Pharma

    Quality in the pharmaceutical industry extends far beyond inspections, CAPAs, SOPs, and compliance activities. While these elements are important, they represent only individual components of a much larger system. In this episode of The GMP Insider, we explore the broader meaning of quality…

    more

About this show

GMP Insider is your go-to podcast for practical insights into pharmaceutical quality, Good Manufacturing Practices (GMP), and regulatory compliance.Designed for quality professionals, manufacturing teams, and pharma leaders, this show breaks down complex regulations into clear, real-world guidance. Each episode explores topics like audits, CAPA, data integrity, quality systems, validation, and global regulatory expectations — all with a focus on protecting patients and building strong quality cultures.Whether you work in Quality Assurance, Quality Control, Manufacturing, or Regulatory Affairs, GMP Insider helps you stay compliant, confident, and ahead in an ever-evolving pharmaceutical industry.New episodes deliver:• GMP best practices• Audit readiness strategies• Real compliance case studies• Industry trends and updates• Expert tips from quality professionals From batch to patient — quality is everything.

Hosted by

Tushar Arora

Categories

Frequently asked questions

How many episodes does The GMP Insider have?

The GMP Insider has 80 episodes on PodParley. The most recent episode was published on November 16, 2026.

What is The GMP Insider about?

GMP Insider is your go-to podcast for practical insights into pharmaceutical quality, Good Manufacturing Practices (GMP), and regulatory compliance.Designed for quality professionals, manufacturing teams, and pharma leaders, this show breaks down complex regulations into clear, real-world guidance....

How often does The GMP Insider release new episodes?

The GMP Insider publishes a few times a week, based on its 80 episodes since January 2026.

Who hosts The GMP Insider?

The GMP Insider is created and hosted by Tushar Arora.
Link copied